Target intelligence / Profile preview

MicroRNA 4320 (MIR4320)

Target
MIR4320
Molecular classification
Non-coding RNA, MicroRNA (miRNA)
01

Overview

MicroRNA 4320 (MIR4320) is a small non-coding RNA (typically 20–24 nucleotides) involved in regulating gene expression after transcription, primarily by interfering with the stability and translation of messenger RNAs through interaction with the RNA-induced silencing complex (RISC)[1][2][3][6]. It is encoded by the MIR4320 gene (HGNC: 38369), and its mature form is processed by Drosha and Dicer enzymes. Like other miRNAs, MIR4320 can modulate cellular processes by silencing or activating gene expression and may circulate extracellularly as a chemical messenger[6]. MIR4320 has been linked to intracranial berry aneurysm according to gene association databases, although its broader physiological and pathological roles remain to be determined[1].

Other names
MIR4320hsa-mir-4320
02

Mechanism of action

Drugs targeting microRNA generally act via inhibition of microRNA function, restoration of normal gene expression, or modulation of downstream targets. Mechanisms include blocking the seed region, altering miRNA stability, or binding to miRNA-mRNA complexes[3][6][7].

03

Biological functions

Post-transcriptional regulation of gene expressionmRNA destabilization (degradation)Translational inhibition of target mRNAsCell-cell communication (via extracellular/circulating miRNAs)
04

Disease associations

Intracranial berry aneurysm (associated by GeneCards)Potential involvement in other diseases; many miRNAs play roles in cancer, inflammation, and cardiovascular disease, but no specific literature links MIR4320 to these yet
05

Safety considerations

miRNA-targeting drugs may affect multiple gene networks, leading to off-target effects or broad pathway impacts; no specific concerns for MIR4320 reported

Beyond the preview

Go deeper on MicroRNA 4320 (MIR4320).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4320 (MIR4320).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call